reported satisfaction rates of 87-90% in long-term followup (3). Since its introduction, use of AUS has also expanded to the management of SUI caused by transurethral procedures, radiation therapy, intrinsic sphincter deficiency, neurogenic bladder, congenital disorders, and orthotopic neobladder urinary diversion (4,5).The standard device, the AMS 800 AUS, is traditionally implanted using a combined perineal and abdominal approach, which requires two incisions: a perineal incision for placement of the cuff, and a suprapubic incision for